These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 15698872)

  • 1. Selecting patients for sacral nerve stimulation.
    Siegel SW
    Urol Clin North Am; 2005 Feb; 32(1):19-26. PubMed ID: 15698872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient selection for sacral nerve stimulation.
    Butrick CW
    Int Urogynecol J; 2010 Dec; 21 Suppl 2():S447-51. PubMed ID: 20972547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of pelvic-floor therapy in the treatment of lower urinary tract dysfunctions in children.
    De Paepe H; Renson C; Hoebeke P; Raes A; Van Laecke E; Vande Walle J
    Scand J Urol Nephrol; 2002; 36(4):260-7. PubMed ID: 12201917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sacral neuromodulation in the older woman.
    McAchran SE; Daneshgari F
    Clin Obstet Gynecol; 2007 Sep; 50(3):735-44. PubMed ID: 17762421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of magnetic stimulation in the treatment of pelvic floor dysfunction.
    Voorham-van der Zalm PJ; Pelger RC; Stiggelbout AM; Elzevier HW; Lycklama à Nijeholt GA
    BJU Int; 2006 May; 97(5):1035-8. PubMed ID: 16643487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current perspectives on management of urgency using bladder and behavioral training.
    Burgio KL
    J Am Acad Nurse Pract; 2004 Oct; 16(10 Suppl):4-7. PubMed ID: 15543926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sacral neuromodulation as an effective treatment for refractory pelvic floor dysfunction.
    Aboseif S; Tamaddon K; Chalfin S; Freedman S; Kaptein J
    Urology; 2002 Jul; 60(1):52-6. PubMed ID: 12100921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of transvaginal biofeedback and electrical stimulation in women with urinary urgency and frequency and associated pelvic floor muscle spasm.
    Bendaña EE; Belarmino JM; Dinh JH; Cook CL; Murray BP; Feustel PJ; De EJ
    Urol Nurs; 2009; 29(3):171-6. PubMed ID: 19579410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of pelvic floor muscle training, electromyography biofeedback, and neuromuscular electrical stimulation for bladder dysfunction in people with multiple sclerosis: a randomized pilot study.
    McClurg D; Ashe RG; Marshall K; Lowe-Strong AS
    Neurourol Urodyn; 2006; 25(4):337-48. PubMed ID: 16637070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous neuromodulation.
    Cooperberg MR; Stoller ML
    Urol Clin North Am; 2005 Feb; 32(1):71-8, vii. PubMed ID: 15698879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuromuscular electrical stimulation and the treatment of lower urinary tract dysfunction in multiple sclerosis--a double blind, placebo controlled, randomised clinical trial.
    McClurg D; Ashe RG; Lowe-Strong AS
    Neurourol Urodyn; 2008; 27(3):231-7. PubMed ID: 17705160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sacral versus pudendal nerve stimulation for voiding dysfunction: a prospective, single-blinded, randomized, crossover trial.
    Peters KM; Feber KM; Bennett RC
    Neurourol Urodyn; 2005; 24(7):643-7. PubMed ID: 16178000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. European experience with bilateral sacral neuromodulation in patients with chronic lower urinary tract dysfunction.
    van Kerrebroeck EV; Scheepens WA; de Bie RA; Weil EH
    Urol Clin North Am; 2005 Feb; 32(1):51-7. PubMed ID: 15698876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pelvic floor muscle training in the treatment of lower urinary tract dysfunction in women with multiple sclerosis.
    Lúcio AC; Campos RM; Perissinotto MC; Miyaoka R; Damasceno BP; D'ancona CA
    Neurourol Urodyn; 2010 Nov; 29(8):1410-3. PubMed ID: 20976816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical Results of PNE Tests in 70 Patients with Different Bladder Dysfunctions].
    Braun PM; Eckermann J; Bross S; Martinez-Portillo FJ; Jünemann KP; Seif C
    Aktuelle Urol; 2003 May; 34(3):162-5. PubMed ID: 14566687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urodynamic evaluation of the bladder and pelvic floor.
    Bradley CS; Smith KE; Kreder KJ
    Gastroenterol Clin North Am; 2008 Sep; 37(3):539-52, vii. PubMed ID: 18793995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pelvic floor spasm as a cause of voiding dysfunction.
    Kuo TL; Ng LG; Chapple CR
    Curr Opin Urol; 2015 Jul; 25(4):311-6. PubMed ID: 26049874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and predictors of complications with sacral neuromodulation.
    White WM; Mobley JD; Doggweiler R; Dobmeyer-Dittrich C; Klein FA
    Urology; 2009 Apr; 73(4):731-5. PubMed ID: 19193415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genitourinary applications of sacral neuromodulation.
    Johnson DN; Vaglienti RM; Huber SJ; Zaslau S
    W V Med J; 2003; 99(3):111-3. PubMed ID: 14515435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sacral nerve neuromodulation in patients with cardiac pacemakers.
    Wallace PA; Lane FL; Noblett KL
    Am J Obstet Gynecol; 2007 Jul; 197(1):94.e1-3. PubMed ID: 17618774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.